Registry of Asthma Patients Initiating DUPIXENT® (RAPID)
Registry of Asthma Patients Initiating DUPIXENT® (RAPID)
The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT® in a real-world setting to understand the attributes of treated patients in real life.
This includes characterization of:
The secondary objectives of the study are:
3-year registry of real-world use of DUPIXENT® for asthma in patients age 12 and over
Key Inclusion Criteria:
Key Exclusion Criteria:
NOTE: Other protocol defined Inclusion/Exclusion criteria apply.
Scottsdale, Arizona 85251, United States
Ann Arbor, Michigan 48106, United States
Manhasset, New York 11030, United States
Oklahoma City, Oklahoma 73131, United States
East Providence, Rhode Island 02914, United States
Québec, G1V 4G5, Canada
Dijon, 21079, France
Kiyosu-shi, Aichi-ken 452-0001, Japan
Kita-ku, Hokkaido 060-8648, Japan
Bunkyo-ku, Tokyo 113-0033, Japan
Chuo-ku, Tokyo 104-0031, Japan
Itabashi-ku, Tokyo 173-8606, Japan
Itabashi-ku, Tokyo 173-8610, Japan
Nakano Ku, Tokyo 164-0012, Japan
Shinagawa-ku, Tokyo 142-8666, Japan
Shinjuku-ku, Tokyo 162-8666, Japan
Sumida-ku, Tokyo 130-8587, Japan